{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:25:09Z","timestamp":1793319909648,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.thromres.2023.06.015","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T03:15:19Z","timestamp":1686885319000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning"],"prefix":"10.1016","volume":"228","author":[{"given":"Andres J.","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Lecumberri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Obispo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Garc\u00eda","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Fanjul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"del Rio-Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"Vi\u00f1uela-Ben\u00e9itez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Hern\u00e1ndez-Presa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.thromres.2023.06.015_bb0005","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","article-title":"Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study","volume":"123","author":"Chee","year":"2014","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.thromres.2023.06.015_bb0010","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.164.15.1653","article-title":"Outcomes and cost of deep venous thrombosis among patients with cancer","volume":"164","author":"Elting","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2023.06.015_bb0015","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.thromres.2023.06.015_bb0020","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2011-05-357343","article-title":"Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study","volume":"118","author":"Heit","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2023.06.015_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study","volume":"117","author":"Cohen","year":"2017","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.thromres.2023.06.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med."},{"issue":"22","key":"10.1016\/j.thromres.2023.06.015_bb0035","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1001\/archinte.160.22.3431","article-title":"Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy","volume":"160","author":"JD","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2023.06.015_bb0040","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with Cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.06.015_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CEOR.S39964","article-title":"Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States","volume":"5","author":"Khorana","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.thromres.2023.06.015_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2023.06.015_bb0055","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.thromres.2023.06.015_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.thromres.2017.01.009","article-title":"Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial","volume":"151","author":"Khorana","year":"2017","journal-title":"Thromb. Res."},{"issue":"32","key":"10.1016\/j.thromres.2023.06.015_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001235","article-title":"Fatal events in Cancer patients receiving anticoagulant therapy for venous thromboembolism","volume":"94","author":"Farge","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.thromres.2023.06.015_bb0070","first-page":"618","article-title":"Edoxaban for the treatment of Cancer-associated venous thromboembolism","volume":"7","author":"Raskob","year":"2019","journal-title":"Journal of Vascular Surgery: Venous and Lymphatic Disorders"},{"issue":"9","key":"10.1016\/j.thromres.2023.06.015_bb0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/s-0038-1668523","article-title":"Apixaban versus Dalteparin for the treatment of acute venous thromboembolism in patients with Cancer: the Caravaggio study","volume":"118","author":"Agnelli","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2023.06.015_bb0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.thromres.2023.06.015_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.thromres.2015.07.011","article-title":"Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants","volume":"136","author":"Posch","year":"2015","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2023.06.015_bb0090","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","article-title":"Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism","volume":"126","author":"Louzada","year":"2012","journal-title":"Circulation"},{"issue":"16_suppl","key":"10.1016\/j.thromres.2023.06.015_bb0095","doi-asserted-by":"crossref","first-page":"e18744","DOI":"10.1200\/JCO.2022.40.16_suppl.e18744","article-title":"Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning","volume":"40","author":"Mu\u00f1oz Mart\u00edn","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.015_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jamia\/ocw042","article-title":"Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review","volume":"24","author":"Goldstein","year":"2017","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"11","key":"10.1016\/j.thromres.2023.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s40264-017-0558-6","article-title":"Natural language processing for EHR-based pharmacovigilance: a structured review","volume":"40","author":"Luo","year":"2017","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.thromres.2023.06.015_bb0110","doi-asserted-by":"crossref","DOI":"10.2196\/12239","article-title":"Natural language processing of clinical notes on chronic diseases: systematic review","volume":"7","author":"Sheikhalishahi","year":"2019","journal-title":"JMIR Med. Inform."},{"issue":"10","key":"10.1016\/j.thromres.2023.06.015_bb0115","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.3390\/jcm9103259","article-title":"Characteristics and prognosis of COVID-19 in patients with COPD","volume":"9","author":"Graziani","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.thromres.2023.06.015_bb0120","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03142-2020","article-title":"The impact of COVID-19 on patients with asthma","volume":"57","author":"Izquierdo","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.thromres.2023.06.015_bb0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jwh.2020.8721","article-title":"Evidence of gender differences in the diagnosis and management of COVID-19 patients: an analysis of electronic health records using natural language processing and machine learning","volume":"30","author":"Ancochea","year":"2021","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"7","key":"10.1016\/j.thromres.2023.06.015_bb0130","doi-asserted-by":"crossref","DOI":"10.2196\/20492","article-title":"Assessing the performance of clinical natural language processing systems: development of an evaluation methodology","volume":"9","author":"Canales","year":"2021","journal-title":"JMIR Med. Inform."},{"issue":"10","key":"10.1016\/j.thromres.2023.06.015_bb0135","doi-asserted-by":"crossref","DOI":"10.2196\/21801","article-title":"Clinical characteristics and prognostic factors for intensive care unit admission of patients with COVID-19: retrospective study using machine learning and natural language processing","volume":"22","author":"Izquierdo","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.thromres.2023.06.015_bb0140","series-title":"Savana: A Global Information Extraction and Terminology Expansion Framework in the Medical Domain Procesamiento del Lenguaje Natural","first-page":"23","volume":"57","author":"Espinosa-Anke","year":"2016"},{"key":"10.1016\/j.thromres.2023.06.015_bb0145","series-title":"Principles of Health Interoperability HL7 and SNOMED","author":"Benson","year":"2012"},{"issue":"2","key":"10.1016\/j.thromres.2023.06.015_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.arbres.2019.12.025","article-title":"Clinical management of COPD in a real-world setting. A big data analysis","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.thromres.2023.06.015_bb0155","series-title":"Leveraging Data Science for Global Health","first-page":"219","article-title":"Robust predictive models in clinical data\u2014Random Forest and support vector machines","author":"Liu","year":"2020"},{"issue":"1","key":"10.1016\/j.thromres.2023.06.015_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.thromres.2023.06.015_bb0165","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1055\/s-0040-1712098","article-title":"Direct Oral anticoagulants for the treatment of acute venous thromboembolism associated with Cancer: a systematic review and meta-analysis","volume":"120","author":"Giustozzi","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2023.06.015_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12736","article-title":"Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: the RIETECAT study","volume":"6","author":"Trujillo-Santos","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.thromres.2023.06.015_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejim.2020.05.031","article-title":"A snapshot of cancer-associated thromboembolic disease in 2018-2019: first data from the TESEO prospective registry","volume":"78","author":"Carmona-Bayonas","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.thromres.2023.06.015_bb0180","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2023.06.015_bb0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MBC.0b013e328341f030","article-title":"Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies","volume":"22","author":"Louzada","year":"2011","journal-title":"Blood Coaul Fibrinolysis"},{"key":"10.1016\/j.thromres.2023.06.015_bb0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1160\/TH08-02-0125","article-title":"Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE registry","volume":"100","author":"Trujillo-Santos","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.06.015_bb0195","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/jth.14783","article-title":"Prognosis in patients with cancer-associated venous thromboembolism: comparison of the RIETE-VTE and modified Ottawa score","volume":"18","author":"Pfaundler","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.06.015_bb0200","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/jth.12192","article-title":"Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosis","volume":"11","author":"den Exter","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.06.015_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1486-7497","article-title":"Failure of the Ottawa score to predict the risk of recurrent venous thromboembolism in Cancer patients: the prospective PREDICARE cohort study","volume":"122","author":"Girard","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.06.015_bb0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2019.07.005","article-title":"The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism","volume":"181","author":"Mulder","year":"2019","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2023.06.015_bb0215","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3324\/haematol.2019.222828","article-title":"Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis","volume":"105","author":"Delluc","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.thromres.2023.06.015_bb0220","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.thromres.2015.07.004","article-title":"Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: a nationwide family study","volume":"136","author":"Zoller","year":"2015","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:22Z","timestamp":1758736342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482300186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":44,"alternative-id":["S004938482300186X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.06.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}